» Articles » PMID: 17686153

The Role of the N-terminal Segment of CCR5 in HIV-1 Env-mediated Membrane Fusion and the Mechanism of Virus Adaptation to CCR5 Lacking This Segment

Overview
Journal Retrovirology
Publisher Biomed Central
Specialty Microbiology
Date 2007 Aug 10
PMID 17686153
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: HIV-1 envelope glycoprotein (Env) induces membrane fusion as a result of sequential binding to CD4 and chemokine receptors (CCR5 or CXCR4). The critical determinants of CCR5 coreceptor function are the N-terminal domain (Nt) and the second extracellular loop. However, mutations in gp120 adapt HIV-1 to grow on cells expressing the N-terminally truncated CCR5(Delta 18) (Platt et al., J. Virol. 2005, 79: 4357-68).

Results: We have functionally characterized the adapted Env (designated Env(NYP)) using a quantitative cell-cell fusion assay. The rate of fusion with target cells expressing wild-type CCR5 and the resistance to fusion inhibitors was virtually identical for wild-type Env and Env(NYP), implying that the coreceptor affinity had not increased as a result of adaptation. In contrast, Env(NYP)-induced fusion with cells expressing CCR5(Delta 18) occurred at a slower rate and was extremely sensitive to the CCR5 binding inhibitor, Sch-C. Resistance to Sch-C drastically increased after pre-incubation of Env(NYP)- and CCR5(Delta 18)-expressing cells at a temperature that was not permissive to fusion. This indicates that ternary Env(NYP)-CD4-CCR5(Delta 18) complexes accumulate at sub-threshold temperature and that low-affinity interactions with the truncated coreceptor are sufficient for triggering conformational changes in the gp41 of Env(NYP) but not in wild-type Env. We also demonstrated that the ability of CCR5(Delta 18) to support fusion and infection mediated by wild-type Env can be partially reconstituted in the presence of a synthetic sulfated peptide corresponding to the CCR5 Nt. Pre-incubation of wild-type Env- and CCR5(Delta 18)-expressing cells with the sulfated peptide at sub-threshold temperature markedly increased the efficiency of fusion.

Conclusion: We propose that, upon binding the Nt region of CCR5, wild-type Env acquires the ability to productively engage the extracellular loop(s) of CCR5 - an event that triggers gp41 refolding and membrane merger. The adaptive mutations in Env(NYP) enable it to more readily release its hold on gp41, even when it interacts weakly with a severely damaged coreceptor in the absence of the sulfopeptide.

Citing Articles

Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands.

Anitha A, Narayanan P, Ajayakumar N, Sivakumar K, Kumar K J Biochem. 2022; 172(3):149-164.

PMID: 35708645 PMC: 9445593. DOI: 10.1093/jb/mvac052.


Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env.

Schapiro H, Khasnis M, Ahn K, Karagiaridi A, Hayden S, Cilento M PLoS Pathog. 2022; 18(5):e1010531.

PMID: 35584191 PMC: 9154124. DOI: 10.1371/journal.ppat.1010531.


Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators.

Zhang S, Holmes A, Dick A, Rashad A, Enriquez Rodriguez L, Canziani G Retrovirology. 2021; 18(1):31.

PMID: 34627310 PMC: 8501640. DOI: 10.1186/s12977-021-00575-z.


Complex interplay of kinetic factors governs the synergistic properties of HIV-1 entry inhibitors.

Ahn K, Root M J Biol Chem. 2017; 292(40):16498-16510.

PMID: 28696261 PMC: 5633110. DOI: 10.1074/jbc.M117.791731.


Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 Trimer.

Khasnis M, Halkidis K, Bhardwaj A, Root M PLoS Pathog. 2016; 12(12):e1006098.

PMID: 27992602 PMC: 5222517. DOI: 10.1371/journal.ppat.1006098.


References
1.
Abrahamyan L, Mkrtchyan S, Binley J, Lu M, Melikyan G, Cohen F . The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle. J Virol. 2004; 79(1):106-15. PMC: 538707. DOI: 10.1128/JVI.79.1.106-115.2005. View

2.
Chabot D, Zhang P, Quinnan G, Broder C . Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates. J Virol. 1999; 73(8):6598-609. PMC: 112744. DOI: 10.1128/JVI.73.8.6598-6609.1999. View

3.
Platt E, Shea D, Rose P, Kabat D . Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan. J Virol. 2005; 79(7):4357-68. PMC: 1061536. DOI: 10.1128/JVI.79.7.4357-4368.2005. View

4.
Mkrtchyan S, Markosyan R, Eadon M, Moore J, Melikyan G, Cohen F . Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion. J Virol. 2005; 79(17):11161-9. PMC: 1193594. DOI: 10.1128/JVI.79.17.11161-11169.2005. View

5.
Huang C, Tang M, Zhang M, Majeed S, Montabana E, Stanfield R . Structure of a V3-containing HIV-1 gp120 core. Science. 2005; 310(5750):1025-8. PMC: 2408531. DOI: 10.1126/science.1118398. View